Between 2001 and 2004, incidence rates of invasive breast cancer declined more than 8% in the United States (US), with the greatest drops observed for estrogen receptor-positive (ER+) tumors among women aged 50 years and over [1-8]. The gene discussed is ESR1; the disease is invasive breast carcinoma.